QA: Altrazeal Life Sciences Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001168220_2018_Altrazeal_Life_Sciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}

Graph

Absolute values for 0001168220, Altrazeal Life Sciences Inc.

  xvar xval
0 AssetsCurrent 4,635,152
1 IntangibleAssetsNetIncludingGoodwill 179,737
2 PropertyPlantAndEquipmentNet 53,723
3 remainder_Assets 3,674,705
4 LiabilitiesCurrent 1,512,634
5 LiabilitiesNoncurrent 922,887
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,478,018
9 ResearchAndDevelopmentExpense 239,948
10 remainder_Expenses 1,158,372
11 remainder_Revenues 717,157
12 remainder_NetIncome 222,893
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 8,543,317
1 Liabilities 2,435,521
2 Expenses 2,876,338
3 Revenues 717,157
4 StockholdersEquity 6,107,796
5 NetIncome -1,936,288
6 ComprehensiveNetIncome -1,936,288
7 BaseVar 7,397,613
8 EconomicCapitalRatio 1.56

Edgar->Model Mapping

Feature Distribution

Change over Time